Prelude Capital Management, LLC Arbutus Biopharma Corp Transaction History

Prelude Capital Management, LLC

  • $1.85 Billion
  • Q1 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$2.24 - $3.06 $27,796 - $37,971
-12,409 Reduced 39.77%
18,790 $43,000
Q1 2023

May 15, 2023
SELL
$2.23 - $3.1 $19,958 - $27,745
-8,950 Reduced 22.29%
31,199 $94,000
Q4 2022

Feb 14, 2023
SELL
$1.91 - $2.85 $26,220 - $39,124
-13,728 Reduced 25.48%
40,149 $93,000
Q3 2022

Nov 14, 2022
SELL
$1.88 - $2.88 $27,613 - $42,301
-14,688 Reduced 21.42%
53,877 $103,000
Q2 2022

Aug 15, 2022
BUY
$1.98 - $3.17 $17,948 - $28,736
9,065 Added 15.24%
68,565 $186,000
Q1 2022

May 16, 2022
BUY
$2.42 - $3.98 $36,784 - $60,496
15,200 Added 34.31%
59,500 $177,000
Q4 2021

Feb 14, 2022
BUY
$3.11 - $4.61 $16,483 - $24,433
5,300 Added 13.59%
44,300 $172,000
Q3 2021

Nov 15, 2021
BUY
$2.65 - $4.62 $103,350 - $180,180
39,000 New
39,000 $167,000
Q1 2021

May 17, 2021
SELL
$3.14 - $4.84 $141,614 - $218,284
-45,100 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$2.76 - $4.97 $276 - $497
100 Added 0.22%
45,100 $160,000
Q3 2020

Nov 16, 2020
BUY
$1.75 - $6.2 $78,750 - $279,000
45,000 New
45,000 $141,000
Q4 2017

Feb 14, 2018
SELL
$4.45 - $7.7 $15,130 - $26,180
-3,400 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$3.4 - $7.0 $11,560 - $23,800
3,400
3,400 $21,000

Others Institutions Holding ABUS

# of Institutions
130
Shares Held
82.2M
Call Options Held
4.82M
Put Options Held
546K
View Full List

About Arbutus Biopharma Corp

ABUS Quotes by TradingView
  • Ticker ABUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,951,008
  • Market Cap $489M
  • Description
  • Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...
More about ABUS
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email